TRANSPLANT Flashcards

1
Q

Class I HLA antigen are found on what cells

A

all nucleated cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Class II HLA are found on wet cells

A
antigen presenting cells:
Macrophage
Dendritic cells
B. lymphocytes
Monocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

corticosteroid

use, mechanism, side effects

A

maintenance, rejection

IL1 released

Posttransplant diabetes, hypertension, osteonecrosis, Cushing’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

azathioprine

use, mechanism, side effects

A

maintenance

Azathioprine (purine) block

Inhibits nuclaic acid syntheis (DNA) - the we will do him suppressing proliferation of activated B and T-cells

bone marrow depression, 
hepatic venoocclusive disease, 
pancreatitis, 
RBC achalasia, 
arthralgia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

cyclosporine

use, mechanism, side effects

A

maintenance

C=C CALCINEURIN cyst is in

L2 secretion and formation inhibition
Inhibits calcineurin

Nephrotoxic-interstitial fibrosis and arteriolar lesions blood
Hepatotoxicity
Hypertension
Hyperkalemia
Hirsutism
Gingival hyperplasia
Tremors
Headache
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

drug inhibits IL-2 synthesis

A

tacrolimus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

tacrolimus

use, mechanism, side effects

A

(FK506, Prograft)

 maintenance
 refractory rejection  (rescue)

IL-2 synth / production

Nephrotoxic
Glucose intolerance
Neuro toxic
hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

mycophenolate mofetil

use, mechanism, side effects

A

(CellCept)

Maintenance

Inosine monophosphate dehydrogenase inhibition

Neutropenia
GI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sirolimus

use, mechanism, side effects

A

maintenance

TOR inhibitor
( target of rapamycin)

THROMBOCYTOPENIA
neutropenia
Impaired wound healing
Dyslipidemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

OKT3

use, mechanism, side effects

A

(Monoclonal antibody)

treatment of rejection

Depletion of T cells
receptors surface T-cell

fever/chills
Pulmonary edema
LYMPHOPROLIFERATIVE disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Polyclonal anti-lymphocyte

use, mechanism, side effects a

A

induction therapy
treatment of rejection

Decreased lymphocytes

ANAPHYLAXIS
Leukopenia
Thrombocytopenia
LYMPHOPROLIFERATIVE disorder
 cytokine release syndrome
Fever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Daclizumab and Basiliximab

A

induction therapy

IL2 receptor blockade

Minimal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how does cyclosporine inhibit T-cell activation

A

inhibit calcineurin As primary mechanism secondary effect is IL-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

University of Wisconsin solution

A

raffinose
hydroxyethyl starts
lactobionate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

rejection and start on postoperative day 2

A

accelerated acute rejection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hyperacute rejection

A

minutes to hours

Antibody mediated

Preformed antibiotics to ABO blood blood group or HLA antigens

In the field and necrosis
Vascular thromboses
Flaccid
Cyanotic
anuric
PMNs packed and peri-capillary
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Accelerated acute rejection

A

Days

Memory response to prior sensitization
Rare difficult to control
Early graft loss

Cellular and antibody mediated injury

More, and went recipient has been sensitized by previous antigen exposure

Kidney-oliguria
disseminated intravascular coagulation
Thrombocytopenia
Hemolysis

Swollen organ
Tender
Congestive

Arterial necrosis
Perry vasculitis
Glomerular basement membrane CD4 deposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

acute rejection

A

days to months

Predominantly cell-mediated:
Lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Chronic rejection

A

slow progressive of months to years

Immune and nonimmune mechanisms involved

Vascular intimal hyperplasia
Lymphocytic infiltration
Atrophy
Fibrosis

Delayed type hypersensitivity
Chronic ischemia
Antibiotic formation

Causing her inhibitor toxicity is a risk

TGF beta may be a risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

the most significant side effect of s sirolimus

A

thrombocytopenia

Other side effects:
Neutropenia
Impaired wound healing
Increased lipids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

cyclosporine levels are affected by what drugs

A

p450 complication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Inducers of the P450 system

A

Phenytoin ramp up p450

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Inhibitors or competitive ears with the P450 system

A

Inhibitors or competitive ears with the P450 system

Erythromycin
Cimetidine
Ketoconazole
Fluconazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Living donor bowel is removed for transplant
How much length
was blood supply

A

mid ileum to distal ileum-the good part

This is about 200 cm

ileocolic vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Acceptable cold ischemia time for kidney
36-40 hours left delayed graft function
26
Acceptable cold ischemia for pancreas
less than 24 hours left duodenal leaks due to pancreatitis
27
Acceptable cold ischemia for liver
less than 16 hours Associated with left hepatic dysfunction Biliary complications
28
The acceptable ischemia time the heart and lung
less than 6 hours! Cold ischemia not an option
29
Most appropriate treatment for lymphocele after renal transplant
Laparoscopic or open peritoneal window another option is percutaneous catheter with or without sclerotherapy - associated with some risk of recurrence or infection Not percutaneous aspiration
30
Describe complications associated with lymphocele after renal transplant
Easily over 2 weeks after transplant Mass effect: Ureter Iliac pain Allograft renal artery Hypertension Unilateral leg swelling Elevated creatinine Diagnoses: Ultrasound for confirmation
31
the major cause of death after Renal transplantation
cardiovascular: Myocardial infarction Stroke
32
less common causes of death following renal transplantation
sepsis 3% | Malignancy 2%
33
The leading cause of graft loss following renal transplantation
recipient death-usually cardiovascular Second most common past chronic allograft nephropathy-slow deterioration of graft function
34
Graft failure due to surgical technique percentage
2%
35
Back table preparation for donor pancreas prior to transplantation includes
Placement of arterial graft to connect the splenic and superior mesenteric arteries
36
the most common cause of liver failure in patient undergoing liver transplantation
hepatitis C United States | Left commonly hepatitis B
37
Milan criteria
single lesion less than 5 One-3 tumors each less than 30 Absence of vascular or lymphatic invasion
38
indications for liver transplant in acute liver failure
Fulminant hepatic failure different criteria and chronic: acetaminophen: PH less than 7.3 INR greater than 6.5 Creatinine greater than 3.4 ``` NON--acetaminophen: INR greater than 6.5 Creatinine greater than 3.4 age less than 10 or greater than 40 non-a non-b hepatitis ( type C) Duration of jaundice before encephalopathy greater than 7 days ```
39
Defined fulminant hepatic failure
hepatic encephalopathy and profound coagulopathy short after the onset of symptoms such as jaundice and patient's WITHOUT pre-existing liver disease
40
Most common causes of fulminant hepatic failure
``` United States in West acetaminophen Acute hepatitis B Hepatic toxins Wilson's disease Often idiopathic ```
41
Component of the MELD score
INR Creatinine Total bilirubin
42
Most, vascular complication after liver transplantation
Hepatic artery thrombosis Most common early event May cause ischemia to common bile duct with diffuse biliary leak or stricture 3-5% adult 5-10% children Increase with partial transplant Initial diagnosis Doppler ``` Treatment: Urgent reexploration Thrombectomy REVISION of anastomosis May require re\re transplant is extensive necrosis ``` Later events: Stenosis Pseudoaneurysm
43
posttransplant lymphoproliferative disorder as caused by, Presentation, treatment
Epstein-Barr he asymptomatic is possible mononucleosis syndrome Hepatitis Posttransplant lymphoproliferative disorder: may present as localized tumor of the lymph nodes or GI tract or rarely rapidly progressive diffuse fatal lymphomatous infiltration
44
Most common indication for pediatric liver transplantation
Biliary atresia Others: Sclerosing cholangitis Familial cholestasis syndrome Lack of intrahepatic bile ducts (ALAGILLE syndrome Metabolic disorder: Alpha-1 antitrypsin deficiency-most common Tyrosinemia - hereditary enzyme deficiency so cannot degrade tyrosine-results and cirrhosis with greatly increased risk of hepatocellular carcinoma Wilson's disease
45
Up for an anti-traction deficiency
Metabolic disorder Presentation: Jaundice as a neonate but then resolves often Subsequent presentation: Childhood or early less than Cirrhosis Portal hypertension
46
Wilson's disease Autosomal recessive Proper cannulation in the liver, CNS, kidneys, eyes, other organs
May present form and, supplements, chronic liver failure
47
after transplantation, patient's are at increased risk for which malignancy
``` Kaposi's sarcoma Skin cancers Lymphoproliferative disease Gynecologic cancer Urologic cancer ```
48
which transplant recipients are at the most increased risk for cancer
kidney 1% Small bowel and multiple visceral transplants 5-6% of
49
5 year graft survival rate after renal transplantation
75-80% 60-65 cm
50
Main advantage of bladder drainage with pancreaticoduodenal transplant
Direct measure and enzyme activity in urine to follow exocrine function with urine amylase serum amylase is less sensitive Urine amylase decreases before hyperglycemia recurrence Leak rate is the same for enteric anastomosis
51
Disadvantage of bladder drainage with pancreaticoduodenal transplant
Bladder leak is much more severe when compared to bile leak Dehydration Acidosis from loss of a clotted pancreatic secretions into the urine Bladder infection, hematuria, stones, urethritis 10-20% of the bladder drained graft recipient are converted to an enteric drainage
52
Advancement of the enteric drainage for pancreatic transplant
More physiologic | decreased long-term complications
53
Powders rejection effect simultaneous pancreas and kidney transplant
almost always affects both kidney and pancreas Therefore creatinine level can be used as a marker for rejection of pancreas Most centers use enteric drainage for simultaneous pancreas and kidney transplant His kidney and pancreas are from different donors or if there is pancreas transplant alone bladder drainage is preferred
54
absolute contraindication for orthotopic cardiac transplant
``` severe hypertension Advanced age over 65 Cardiac trauma Coronary artery disease medical noncompliance renal insufficiency ``` Active infection does not equal uncontrolled infection
55
Contraindications for organ specific donation
``` Medical problems Malignancy other than primary brain tumor ( or skin cancer which can be treated with excision) Prolonged cardiac arrest Uncontrolled infection HIV? ```
56
And a liver be transplanted with hepatitis B positive
yes IF kidneys are normal Recipient appropriate serologic and viral profile to oppose minimal risk
57
Hepatitis C positive liver donation
Yes normal liver biopsy required
58
Can organ to be donated from patient's with high risk factors
``` no except an emergency situation Sexual behavior Intravenous drug Correctional institution ```
59
expanded criteria for kidney donation
old and 60 with a history of hypertension, cerebrovascular accident as cause of death And final procurement creatinine greater than 1.5 mild hypertension may not be a contraindication though severe hypertension is absolute contraindication
60
age as a contraindication for donation
relative
61
contraindications for kidney donation
pre-existing renal disease
62
Contraindication for pancreas donation
diabetes
63
contraindications for heart lung donation
cardiac trauma Coronary artery disease Pneumonia
64
age when donor is considered older - and workup needed
35-40 may require a coronary catheterization rule out significant and cardiac disease
65
contraindications for lung donation
pneumonia Pulmonary trauma Respiratory compromise may require bronchoscopy for inspection evaluation
66
heterotopic cardiac transplant
patient's native right heart continues to work against pulmonary hypertension - option sometimes used when patient has pulmonary hypertension No heart supplies systemic circulation
67
Absolute contraindications for DONATION of heart
prolonged cardiac arrest Carbon monoxide greater than 20% Significant smoking history
68
most common cause of renal failure and United States
Diabetes
69
Best test to monitor the development of acute rejection and cardiac transplant
Endomyocardial biopsy Current indications the patient clinically and for
70
absolute contraindications for renal transplant in a patient with chronic renal failure
chronic active hepatitis | Recent operation for colon cancer-recommend 5 year disease-free interval
71
Relative contraindications for renal transplant in patient with chronic renal failure
sickle cell disease HIV?
72
absolute contraindications for kidney donation
age over 70 Chronic renal insufficiency Intravenous drug use Severe hypertension
73
which organ is ABO compatibility less important pretransplant
liver
74
criteria for brain death
clinical diagnosis only No barbiturates hypothermia not dead until warm and dead acute metabolic derangement No spontaneous respiration Absent pupillary reflex Absent corneal reflex Apnea sustained with disconnection ventilator transplant team is pronounced patient ( not transplant surgeon) the ``` confirmatory tests cannot be used for final diagnoses: cerebral angiography electroencephalography transcranial Doppler cerebral scintigraphy ```
75
preservation of bone skin dura
cryopreservation
76
Matching required bone skin dura
none ABO not required
77
how is cross-matching done
recipient screened for preformed HLA antibodies screening: Donor lymphocytes mixed with recipient serum to evaluate if there are recipient antibodies combined to donor lymphocytes crossmatch: Final test Donor lymphocyte mixed with the patient's serum
78
Absolute contraindication to kidney transplant crossmatch results
a positive T-cell CDC crossmatch
79
Isograft
identical monozygotic twin Does not require immunosuppression
80
organ besides bone skin dura the does not require immunosuppression
the eyes are in no privileged site because no lymphatic drainage or ejection does occur palpable steroid used a
81
Percentage crossmatch and family genetics
each recipient shears one of 2 haplotype with each parent 25% chance assuring both haplo types: " HLA identical" 25% chance of not showing any haplotype 50% chance of sharing one haplotype
82
along the most renal transplant recipients weight before organ is available
3-7 years less than six-month weight time on dialysis 2 times better graft survival than waiting over 2 years
83
What is arterial inflow most commonly for renal transplant
external iliac
84
Which side is kidney transplant done on
right side external iliac vessels are more superficial
85
what side is preferred to donate kidney from
left to longer vein
86
How do you handle multiple renal vessels
extra artery must be used because of segmental perfusion-use epigastric vessel is extra inflow Can tie off extra vein
87
most common complication after renal transplant
wound infection 4-7 days
88
Thrombosis of renal vein posttransplant
immediate exploration Symptoms of decreased urine output
89
and should renal transplant patient received prophylactic antibiotics post transplant
yes: Bactrim Antifungal
90
CMV infection
Fever Weakness GI bleed Esophagitis Treatment Valganciclovir
91
Artery inflow for pancreatic transplant
splenic | Superior mesenteric using iliac artery Y graft (iliac artery from the recipient)
92
doses portal enteric drainage for pancreatic transplant increased risk of pancreas thrombosis
no and no increased risk of infection urinary tract infections are higher with bladder drainage
93
Liver transplantation for hepatocellular carcinoma
Stage I-2 T1 or T2 No invasion of larger vascular structure No extrahepatic disease
94
is crossmatch required for liver transplant
no
95
liver transplant in adults which lobe is donated from living donor
right
96
liver transplant in children which lobe was donated from living donor
left - because smaller
97
Specific indications for cardiac transplant
``` cardiomyopathy Ischemic cardiac disease Postpartum cardiomyopathy Terminal cardiac valvular disease Hypertensive cardiomyopathy ```
98
What can help bridge cardiac failure patient's transplant
ventricular assist device
99
match requirement for an cardiac transplant
ABO Tissue typing not usually done preoperatively Under 6 hour preservation time
100
Cancers common after cardiac transplant
skin cancer Posttransplant lymphoproliferative disorder Lung cancer
101
heart-lung transplant | performed when
severe pulmonary hypertension with cardiac disease associated with congenital heart disease: Eisenmenger's
102
signs of acute and chronic rejection of lung transplant
bronchiolitis
103
one year survival rate for a heart-lung transplant recipients
63%
104
indicators for need of lung transplant
FEV1 less than 25% PCO2 greater than 55 Increased pulmonary artery pressure
105
can patient with lung cancer a lung transplant
no
106
Does bilateral lung transplant have better survival than single lung
yes
107
what is likely to compromise single lung transplant
emphysema-air trapping in need of long compresses transplant lung Cystic fibrosis History of chronic wound infection
108
Contraindications for bowel transplant
uncontrolled infection Uncontrolled malignancy
109
technical aspects of bowel transplant
heterotopic were orthotopic anastomosis may be brought up to abdominal wall at ileostomy to allow observation and biopsy monitor rejection or ischemia venous anastomosis easily to recipient cava but may be due to portal vein arterial anastomosis to abdominal aorta
110
survival after bowel transplant
80% one year 67% 3 years 54% 5 years 43% 10 years
111
sirolimus most common complications
The most common adverse effects of sirolimus are hyperlipidemia and myelosuppression. Postmarketing studies have revealed a number of unforeseen adverse effects, including impaired wound healing and possibly proteinuria, edema, pneumonitis, and thrombotic microangiopathy. The incidence of abnormal wound healing with sirolimus is 1% to 12%.
112
CMV infection after solid organ transplantation
one of the most common viral infections, Presentation of early CMV colitis can be mild and nonspecific, including mild diarrhea, associated fever, and abdominal pain. A more reliable diagnosis can be made via early and rapid colonoscopy with mucosal biopsies and documentation of the typical colonoscopic and histopathologic findings compatible with CMV colitis. Although serology is helpful in the diagnosis, sometimes it is inadequate. Serum CMV IgM and CMV pp65 antigenemia may be negative. Standard antiviral (ganciclovir, foscarnet) treatment is recommended. Operation (colectomy) is indicated for life-threatening complications (perforation, bleeding, ischemia) or lack of response to medical management.
113
Organ transplant recipients are at particular risk for what skin cancer
Organ transplant recipients are at particular risk for squamous cell carcinoma (SCC). Heart transplant patients have a threefold risk of NMSC over renal transplant recipients who have more NMSC than liver recipients. Cancers in other organ systems are also more common in OTRs compared with nonimmunosuppressed age-matched controls; esophagus [RR 4.7], liver [RR 4.8], cervix [RR 4.6], bladder [RR 5.1], and thyroid [RR 4.5]. The incidence of de novo tumor occurrence is 7% after both kidney and liver transplantation. The median elapsed time from transplant to the diagnosis of de novo malignancy was 45 months for kidney and 37 months for liver transplants. Skin cancers were the most common in renal recipients, while gastroenteric cancers were more frequently seen in liver transplants In renal transplant recipients, the mean incidence per year of NMSC is 8%, comprised equally by SCC and basal cell carcinoma (BCC) and less so by Bowen's disease. Cancers of the skin and lips comprise 40% of all cancers arising after transplantation.
114
type of cancer more commonly seen with liver transplant
gastroenteric cancers were more frequently seen in liver transplants
115
The definition of organ trafcking
the recruitment, transport, transfer, harboring or receipt of persons, by means of the threat or use of force or other forms of coercion, of abduction, of fraud, of deception, of the abuse of power, of a position of vulnerability, of the giving or receiving of payments or benefits to achieve the consent of a person having control over another person, for the purpose of exploitation by the removal of organs, tissues, or cells for transplantation.
116
Transplant tourism a
is a phrase often used interchangeably with organ trafficking but... some medical tourism that entails the travel of transplant recipients or donors across national borders is not organ trafficking. Examples of legal and appropriate transplant tourism include travel of a related donor and recipient pair from countries without transplant services to countries where organ transplantation is performed, or persons traveling across borders to donate or receive a transplant via a relative. The United Network for Organ Sharing (UNOS) recently defined transplant tourism as: the purchase of a transplant organ abroad that includes access to an organ while bypassing laws, rules, or processes of any or all countries involved.
117
reimbursement for personal expense is allowed for transplant donors
no! | Including no reimbursement for personal traveled stents, lost wages, housing...
118
followup care for donors is whose responsibility
is the responsibility of the donor